Editas Medicine Inc reports results for the quarter ended in June - Earnings Summary

Editas Medicine

02/08/2023 14:33

* Editas Medicine Inc  EDIT.OQ  reported a quarterly
adjusted loss
of 56 cents​​ per share for the quarter ended in June. The mean
expectation of seventeen analysts for the quarter was for a loss
of 76 cents per share.
    * Revenue fell 54.6% to $2.89 million from a year ago;
analysts
expected $4.17 million. 
    * Editas Medicine Inc's reported EPS for the quarter was a
loss
of 56 cents​.
    * The mean earnings estimate of analysts had fallen by
about 0.4%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Editas Medicine Inc shares had risen by 5.1% this
quarter and
lost 2.5% so far this year.
    * The company reported a quarterly loss of $40.29 million.
    * Wall Street's median 12-month price target for Editas
Medicine
Inc is $12.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 10
"hold" and 2 "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 2 at 01:33 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.76          -0.56          Beat
 Mar. 31 2023      -0.78          -0.71          Beat
 Dec. 31 2022      -0.80          -0.88          Missed
 Sep. 30 2022      -0.87          -0.81          Beat